Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 May;84(9):3004-8.
doi: 10.1073/pnas.84.9.3004.

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

K Ueda, C Cardarelli, M M Gottesman, I Pastan

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

K Ueda et al. Proc Natl Acad Sci U S A. 1987 May.

Abstract

Intrinsic and acquired multidrug resistance (MDR) is an important problem in cancer therapy. MDR in human KB carcinoma cells selected for resistance to colchicine, vinblastine, or doxorubicin (former generic name adriamycin) is associated with overexpression of the "MDR1" gene, which encodes P-glycoprotein. We previously have isolated an overlapping set of cDNA clones for the human MDR1 gene from multidrug-resistant KB cells. Here we report the construction of a full-length cDNA for the human MDR1 gene and show that this reconstructed cDNA, when inserted into a retroviral expression vector containing the long terminal repeats of Moloney leukemia virus or Harvey sarcoma virus, functions in mouse NIH 3T3 and human KB cells to confer the complete multidrug-resistance phenotype. These results suggest that the human MDR1 gene may be used as a positive selectable marker to introduce genes into human cells and to transform human cells to multidrug resistance without introducing nonhuman antigens.

PubMed Disclaimer

References

    1. J Cell Physiol. 1976 May;88(1):23-31 - PubMed
    1. Cancer Res. 1979 Jun;39(6 Pt 1):2200-3 - PubMed
    1. J Virol. 1980 Nov;36(2):408-20 - PubMed
    1. Cancer Res. 1982 Nov;42(11):4730-3 - PubMed
    1. Mol Cell Biol. 1982 Aug;2(8):881-9 - PubMed